Medical Patent News

RSS

Boston Scientific announces verdict in Cordis patent case

Boston Scientific Corporation has announced that a jury in U.S. District Court in San Francisco has found that Boston Scientific infringes a patent of Cordis Corporation, a subsidiary of Johnson & Johnson, under the doctrine of equivalents.

1 Nov 2007

Nventa Biopharmaceuticals receives new U.S. patent

Nventa Biopharmaceuticals Corporation has announced that the U.S. Patent and Trademark Office has issued Patent Number 7,262,014 to Nventa covering compositions and methods for inducing or enhancing immune responses to a human papillomavirus (HPV) antigen with or without the use of an adjuvant.

29 Oct 2007

Gene screen patent brings 2007 Deal of Distinction Award to UChicagoTech

UChicagoTech, the University of Chicago's Office of Technology and Intellectual Property, has received a 2007 Deal of Distinction Award from the Licensing Executives Society of U.S.A. and Canada.

29 Oct 2007

Sigma-Aldrich and Oxford BioMedica win key ruling in Open Biosystems patent case

Sigma-Aldrich and Oxford BioMedica have announced that they received a key order confirming the strength and validity of intellectual property owned by Oxford BioMedica and licensed exclusively in the research field to Sigma-Aldrich.

25 Oct 2007

Illumina named as defendant in patent infringement suits

Illumina, Inc. (NASDAQ:ILMN) released the following statement by Jay Flatley, its Chief Executive Officer, in response to new patent infringement suits filed yesterday by Affymetrix in Delaware, the United Kingdom and Germany. As of this time, Illumina has yet to be served with these suits.

From Illumina, Inc. 25 Oct 2007

Mylan settles Paroxetine Hydrochloride patent license with GlaxoSmithKline

Mylan Inc. has announced that it and its subsidiary Mylan Pharmaceuticals Inc. have entered into a patent license and settlement agreement with GlaxoSmithKline (GSK) relating to Paroxetine Hydrochloride (HCl) Extended-release (ER) Tablets, the generic version of GSK's Paxil CR.

24 Oct 2007

New method of oral insulin delivery patented

Syracuse University researchers have designed, tested and patented a new method of oral insulin delivery that can potentially help reduce daily insulin injections for millions of people with diabetes who require therapy for optimal glycemic control.

22 Oct 2007

Microbix Biosystems granted U.S. patent for its influenza vaccine

Microbix Biosystems Inc. has been granted a patent by the U.S. Patent Office for its technology - VIRUSMAX - which enables vaccine manufacturers to double the amount of influenza vaccine they produce each year.

22 Oct 2007

Adenoscan patent lawsuits settled

Astellas Pharma Inc., King Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd. have announced that U.S. subsidiaries of Astellas, along with Item Development AB and King have executed settlement agreements with one of Teva's subsidiaries on lawsuits filed in the United States against Teva's subsidiaries regarding their submission of an abbreviated new drug application (ANDA) for a generic version of Adenoscan (adenosine injection), a pharmacologic stress agent.

22 Oct 2007

Accelr8 announces patent allowance for rapid bacterial diagnostic method

Accelr8 Technology Corporation has announced that it received notice of allowance on the first patent related to its BACcel rapid diagnostic platform.

19 Oct 2007

Health Discovery receives notice of allowance of U.S. patent application covering kernel selection methods

Health Discovery Corporation has announced that the U.S. Patent and Trademark Office has issued a notice of allowance of HDC's patent application covering methods for selection of kernels, i.e., functions or algorithms that are used to transform input data into a different configuration, known as "feature space", which allows for easier recognition of patterns within the data.

18 Oct 2007

CryoCath files patent infringement lawsuit

CryoCath Technologies Inc., the global leader in cardiac arrhythmia products to treat cardiovascular disease, today announced it filed against CryoCor, Inc. a patent infringement lawsuit in the United States District Court for the District of Delaware.

17 Oct 2007

AngioGenex files patent on first small molecule Id-inhibitors

AngioGenex Inc. has identified and filed a patent application on small molecules that are potent inhibitors of the Id proteins.

17 Oct 2007

Barr Labs and Par Pharmaceutical settle Diazepam patent case with Valeant

Barr Pharmaceuticals, Inc. today announced that its Barr Laboratories, Inc. subsidiary and Par Pharmaceutical Companies, Inc. have entered into a settlement agreement regarding their joint patent challenge with Valeant Pharmaceuticals North America related to Valeant's DIASTAT(R) diazepam rectal gel products.

15 Oct 2007

Alma Lasers responds to Lumenis patent claim

Alma Lasers Ltd. has filed a response denying all Lumenis' patent infringement claims. Alma Lasers will vigorously defend its position.

From Lumenis Inc. 15 Oct 2007

Aida granted new anti-cancer patent

One of mainland China's leading pharmaceutical companies, has announced that it was granted an additional patent related to its Rh-Apo2L anti-cancer drug, the second of three patents that had been applied for which Aida believes places it at the vanguard of China's pharmaceutical industry.

12 Oct 2007

Brookhaven microgrid allows simultaneous study of multiple variables

Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have developed a method for correlating the results of microscopic imaging techniques in a way that could lead to improved understanding, diagnosis, and possibly treatment of a variety of disease conditions, including Alzheimer's disease. The Laboratory has filed a U.S. provisional patent application for the invention.

10 Oct 2007

Mylan settles Levetiracetam patent case

Mylan Inc. has announced that it and its subsidiary Mylan Pharmaceuticals Inc. have entered into an agreement to settle pending litigation with UCB Societe Anonyme and UCB Pharma Inc. (collectively, UCB) relating to Levetiracetam Tablets, 250mg, 500mg and 750mg, the generic version of UCB's Keppra.

4 Oct 2007

Biodel issued U.S. patent for VIAject and VIAtab

Biodel Inc. has announced the receipt of a notice of issuance from the United States Patent and Trademark Office (USPTO) for the Company's patent encompassing VIAject(TM) and VIAtab(TM), Biodel's two product candidates in clinical trials.

27 Sep 2007

Barr Pharmaceutical's Seasonale patent re-issued

Barr Pharmaceuticals, Inc. has announced that the U.S. Patent and Trademark Office (PTO) has reissued the Company's patent, U.S. Patent No. 5,898,032, for Seasonale extended-cycle oral contraceptive.

26 Sep 2007